Harro Höfliger and DiHeSys form a strategic alliance for the development of medication printing for personalized therapy

DiHeSys and Harro Höfliger form a strategic alliance and make an important contribution to personalized drug therapy for patients. (Source: Ute Huber)

DiHeSys Digital Health Systems GmbH, based in Ulm, and Harro Höfliger Verpackungsmaschinen GmbH, based in Allmersbach im Tal, are pursuing a close strategic partnership in the field of personalized, individualized medicine. Through this collaboration, GMP-compliant printers and drug-containing cartridges are being developed for the production of patient-specific thin films and tablets for broad application in clinics and public pharmacies.

Harro Höfliger is a leading company in the construction of systems for pharmaceutical and medical technology applications. By combining Harro Höfliger's expertise in machinery technology with DiHeSys's know-how in pharmaceutical digital printing and formulation technology, system solutions are being developed that enable physicians and pharmacists to prescribe and produce medicines individually or personalized. Patients can look forward to improved therapy with fewer side effects.

"The synergies provide profound added value for our customers in the healthcare markets, as we combine the core competencies of both companies," says Dr. Markus Dachtler, CEO of DiHeSys. "With this cooperation, we will be able to offer high-quality digital medication printers in pharmaceutical quality, formulations, and drug-containing printing cartridges from a single source. This ensures high-quality medication supply and safety. Additionally, it has a positive ecological effect, as pharmaceutical waste can be significantly reduced."

Thomas Weller (CEO of Harro Höfliger) and Dr. Markus Dachtler agree that personalized therapy – especially considering the ongoing digitalization with increasing amounts of treatment data – will play an important role in the future of healthcare. Thomas Weller: "With this cooperation, we are at the forefront of current developments in digitalization in healthcare and can make an important contribution to personalized medication therapy for all patients in the future."